Global Monoclonal Antibody Partnering Directory 2014-2020: Monoclonal Antibodies, Murine mAb, Chimeric mAb, Humanized mAb, Human aAb
September 24, 2020 05:09 ET
|
Research and Markets
Dublin, Sept. 24, 2020 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2020" report has been added to ResearchAndMarkets.com's offering. The Global...
Global $77.6 Billion In Vitro Diagnostic (IVD) Reagents Market Forecast to 2027: Opportunities in the Growing Demand for Protein Therapeutics and Personalized Medicines
September 17, 2020 05:43 ET
|
Research and Markets
Dublin, Sept. 17, 2020 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Oligonucleotide, Nucleic Acid Probe), Technology (Immunoassay, Hematology,...
2020 Annual Report and Survey on Bio-pharmaceutical Manufacturing Capacity and Production
September 16, 2020 04:13 ET
|
Research and Markets
Dublin, Sept. 16, 2020 (GLOBE NEWSWIRE) -- The "17th Annual Report and Survey on Biopharmaceutical Manufacturing Capacity and Production" report has been added to ResearchAndMarkets.com's offering. ...
Monoclonal Antibody Therapy Market to Reach USD 350.10 Billion by 2027; Increasing Number of Regulatory Approvals Will Aid Growth, says Fortune Business Insights™
September 14, 2020 08:03 ET
|
Fortune Business Insights
Pune, Sept. 14, 2020 (GLOBE NEWSWIRE) -- The global monoclonal antibodies therapy market size is projected to reach USD 350.10 billion by the end of 2027. The increasing prevalence of severe...
Global Small Molecule Cancer Drugs Market 2020-2026: Expected to Double in Next 6 Year Period Reaching $130 Billion, Driven by New Drug Launches & Dynamic Clinical Pipeline
September 01, 2020 04:04 ET
|
Research and Markets
Dublin, Sept. 01, 2020 (GLOBE NEWSWIRE) -- The "Global Small Molecule Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's...
Vir Biotechnology and GSK Start Phase 2/3 Study of COVID-19 Antibody Treatment
August 31, 2020 08:00 ET
|
Vir Biotechnology, Inc.
Phase 2/3 COMET-ICE study will investigate the safety and efficacy of antibody treatment in preventing hospitalization due to COVID-19 Potential for initial study results to be available before the...
Global Immuno-Oncology Diagnostics Market 2019-2023 - Outcome Potential, Companion Diagnostics, Funding, Technology Environment, and Target Solutions Driving Growth
August 27, 2020 06:48 ET
|
Research and Markets
Dublin, Aug. 27, 2020 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Diagnostics: The Race for Biomarkers - Market Forecasts for Immuno-Oncology Diagnostics - With Executive and Consultant Guides and...
Kymab announces that the US Patent Trial and Appeal Board rejects a fifth request by Regeneron for invalidation of Kymab’s US patents
June 03, 2020 07:00 ET
|
Kymab Group Ltd
Kymab announces that the US Patent Trial and Appeal Board rejects a fifthrequest by Regeneron for invalidation of Kymab’s US patents USPTO upholds a fifth Kymab patent covering Human Antibodies and...
Monoclonal Antibody Therapy Market to Rise at 14.0% CAGR till 2027; Growing Investment in Product R&D will Create Several Opportunities for Market Growth, says Fortune Business Insights™
May 11, 2020 11:00 ET
|
Fortune Business Insights
Pune, May 11, 2020 (GLOBE NEWSWIRE) -- The global monoclonal antibodies therapy market size is projected to reach USD 350.10 billion by the end of 2027. The increasing prevalence of severe diseases...
U.S. Non-oncology Biopharmaceuticals Market to Surpass US$ 253.0 Billion by 2026
April 23, 2019 08:45 ET
|
CMI
SEATTLE, April 23, 2019 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the U.S. non-oncology biopharmaceuticals market size is estimated to be valued at US$ 116.0 Billion in 2018, and is...